CD8A and breast carcinoma: In another study, Dong et al. found that knockdown of the DEAH-Box Helicase 37 (DHX37) gene can enhance the response of CD8 + T cells to breast cancer following an in vivo CRISPR screening on CD8 + T cells [39].